FREE DAILY STOCK MARKET NEWS

FREE DAILY STOCK MARKET NEWS

Biotech & Pharmaceutical News

Get latest biotech and pharmaceutical news and expert insights with The Market Bull.
 

The Latest Biotech & Pharmaceutical News

2024 – The Year that Biotech Gets its Vibe Back?

2024 – The Year that Biotech Gets its Vibe Back?

2023 was a challenging year for a lot of listed Companies across the globe, as investor sentiment shifted from bad to worse. Companies operating in the pharmaceutical and biotechnology sectors, in particular, appeared to struggle to attract external investment, as the...

AdAlta Launches $1.23 Million Placement to Advance AD-214

AdAlta Launches $1.23 Million Placement to Advance AD-214

AdAlta Limited (ASX:1AD) is initiating a placement to secure up to A$1.23 million from sophisticated and professional investors to support the analysis of the Phase I extension clinical study for AD-214 and advance ongoing partnership discussions, offering additional...

FivepHusion’s Strategic Partnerships for Success

FivepHusion’s Strategic Partnerships for Success

FivepHusion recently embarked on a strategic partnership with pharmaceutical powerhouse Pfizer, facilitated through its manufacturing subsidiary Pfizer CentreOne®. This was not the first time the small biotech company used a mutually beneficial collaboration to its...

FivepHusion Reach Milestone in Deflexifol™ Clinical Trial

FivepHusion Reach Milestone in Deflexifol™ Clinical Trial

Treatment has commenced for the initial patient in the Deflexifol™ at Relapse Trial (DART), aimed at investigating paediatric ependymoma and other brain cancers, marking a pivotal moment in FivepHusion's journey towards bringing Deflexifol™ to the market. The...

Austco Secure $7.4m Healthcare Communications Contract

Austco Secure $7.4m Healthcare Communications Contract

Austco Healthcare continues its recent streak of wins, with the Company's Canadian Marketing and Service subsidiary securing a massive AUD$7.4 million dollar contract to supply its industry-leading clinical communications system, Tacera to the under-construction St....

FivepHusion Trial Deflexifol™ Brain Tumor Treatment

FivepHusion Trial Deflexifol™ Brain Tumor Treatment

FivepHusion maintains its momentum from its recent successful clinical trial results, with the up-and-coming bio-med company announcing the commencement of its next clinical trial to explore the potential of its flagship Deflexifol™ to treat paediatric brain cancer...

FivepHusion Complete Chemotherapy Clinical Trial

FivepHusion Complete Chemotherapy Clinical Trial

FivepHusion has again demonstrated the potential for its flagship Deflexifol™ to revolutionise the standard of care in 5-FU chemotherapy, with a newly completed dose-escalation clinical study highlighting the superior safety and tolerability of Deflexifol™ over...